OntologiesCurators at RGD make annotations to genes, QTLs and strains using standardized vocabularies/ontologies. Your search returned annotations to the terms below.ChEBI: ChEBI Ontology
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-[(2-methoxyphenyl)methyl]-6-oxo-N-(2-pyridin-4-ylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(3S,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((R)-7-Hydroxy-6-(hydroxymethyl)heptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
3-\{1-[(E)-Allyloxyimino]-butyl\}-4-hydroxy-6,6-dimethyl-2-oxo-cyclohex-3-enecarboxylic acid methyl ester
CID 71298054
ferric hydroxide
Haplanthin
Lentinellic acid
LSM-11903
mannostatin A
N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide
N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide
N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide
N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
N-Eicosapentaenoyl Lysine
S-nitrosomycothiol
Sanguinolentaquinone
CL: Cell Ontology
D1-NUDAP medium spiny neuron
D1/D2-hybrid medium spiny neuron
direct pathway medium spiny neuron
eccentric medium spiny neuron
indirect pathway medium spiny neuron
matrix D1 medium spiny neuron
matrix D2 medium spiny neuron
nucleus accumbens shell and olfactory tubercle D1 medium spiny neuron
nucleus accumbens shell and olfactory tubercle D2 medium spiny neuron
striosomal D1 medium spiny neuron
striosomal D2 medium spiny neuron
TAC3-positive medium spiny neuron
EFO: Experimental Factor Ontology
combined immunodeficiency due to moesin deficiency
moesin
moesin (human)
moesin, initiator methionine removed form
MSN (human)
GO: Biological Process
striatal medium spiny neuron differentiation
MP: Mammalian Phenotype
abnormal medium spiny neuron morphology
RDO: RGD Disease Ontology
immunodeficiency 50
RS: Rat Strains
WMN/Nrs
|
|||||||||||||||||||||||||||||||||||||||||||||||||||



















